Biocon news from FierceBiotech
News
India’s Biocon spinning off its R&D division
India's Biocon is following the footsteps of a lineup of the subcontinent's biopharma companies in spinning off its R&D operations into a separate company. Sun, Wockhardt and Ranbaxy have all Read more...
SPOTLIGHT: Biocon establishing R&D sub
India's Biocon says it will transfer four molecules to a new R&D subsidiary, resisting a trend in the subcontinent of spinning off R&D into a new company. Its researchers are working on new Read more...
SPOTLIGHT: Biocon denies buyout report
Biocon caused a stir this morning after an Indian financial newspaper claimed the country's Read more...
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets